Geode Capital Management
ISEE

Geode Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Geode Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,587,857
Closed -$63M – 4800
2023
Q1 		$63M Buy
2,587,857
+172,028
+7% +$3.77M 0.01% 1018
2022
Q4 		$51.7M Buy
2,415,829
+355,148
+17% +$7.58M 0.01% 1124
2022
Q3 		$37M Buy
2,060,681
+74,646
+4% +$980K 0.01% 1304
2022
Q2 		$19.1M Sell
1,986,035
-4,572
-0.2% -$57.4K ﹤0.01% 1804
2022
Q1 		$33.5M Buy
1,990,607
+11,196
+0.6% +$165K ﹤0.01% 1540
2021
Q4 		$33.1M Buy
1,979,411
+343,337
+21% +$5.63M ﹤0.01% 1615
2021
Q3 		$26.6M Buy
1,636,074
+189,008
+13% +$2.06M ﹤0.01% 1761
2021
Q2 		$9.13M Buy
1,447,066
+112,086
+8% +$723K ﹤0.01% 2519
2021
Q1 		$8.25M Buy
1,334,980
+186,427
+16% +$1.13M ﹤0.01% 2490
2020
Q4 		$7.94M Buy
1,148,553
+84,400
+8% +$540K ﹤0.01% 2319
2020
Q3 		$6M Buy
1,064,153
+499,350
+88% +$2.38M ﹤0.01% 2284
2020
Q2 		$2.88M Buy
564,803
+284,630
+102% +$1.19M ﹤0.01% 2637
2020
Q1 		$963K Buy
280,173
+64,464
+30% +$377K ﹤0.01% 3038
2019
Q4 		$1.85M Buy
215,709
+41,935
+24% +$150K ﹤0.01% 3039
2019
Q3 		$194K Hold
173,774
– – ﹤0.01% 3778
2019
Q2 		$225K Hold
173,774
– – ﹤0.01% 3759
2019
Q1 		$245K Hold
173,774
– – ﹤0.01% 3672
2018
Q4 		$208K Hold
173,774
– – ﹤0.01% 3663
2018
Q3 		$410K Hold
173,774
– – ﹤0.01% 3538
2018
Q2 		$474K Hold
173,774
– – ﹤0.01% 3464
2018
Q1 		$476K Hold
173,774
– – ﹤0.01% 3419
2017
Q4 		$542K Sell
173,774
-12,779
-7% -$35.9K ﹤0.01% 3327
2017
Q3 		$526K Hold
186,553
– – ﹤0.01% 3339
2017
Q2 		$477K Sell
186,553
-54,018
-22% -$147K ﹤0.01% 3372
2017
Q1 		$880K Buy
240,571
+7,501
+3% +$31.7K ﹤0.01% 3078
2016
Q4 		$1.13M Buy
233,070
+8,789
+4% +$261K ﹤0.01% 2932
2016
Q3 		$10.3M Sell
224,281
-181
-0.1% -$10.2K 0.01% 1474
2016
Q2 		$11.5M Buy
224,462
+16,250
+8% +$807K 0.01% 1337
2016
Q1 		$8.8K Sell
208,212
-2,414
-1% -$123K ﹤0.01% 1479
2015
Q4 		$16.5M Buy
210,626
+10,390
+5% +$601K 0.01% 1020
2015
Q3 		$8.11M Buy
200,236
+99,517
+99% +$5.27M ﹤0.01% 1484
2015
Q2 		$5.24M Buy
100,719
+16,654
+20% +$828K ﹤0.01% 1857
2015
Q1 		$3.91M Buy
84,065
+2,066
+3% +$107K ﹤0.01% 2007
2014
Q4 		$3.68M Buy
81,999
+3,222
+4% +$135K ﹤0.01% 2014
2014
Q3 		$3.07M Buy
78,777
+1,481
+2% +$58.1K ﹤0.01% 2097
2014
Q2 		$3.27M Buy
77,296
+14,655
+23% +$538K ﹤0.01% 2076
2014
Q1 		$2.24M Buy
62,641
+7,679
+14% +$259K ﹤0.01% 2269
2013
Q4 		$1.78M Buy
+54,962
New +$1.63M ﹤0.01% 2371

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Geode Capital Management's ISEE Position: Q2 2023 in Review

Geode Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 2,587,857 shares — an estimated $63M sold.

Geode Capital Management first reported a position in ISEE in Q4 2013 and held it in 38 quarters. The position peaked at $63M in Q1 2023. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Geode Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Geode Capital Management sold 2,587,857 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $63M.
  • Geode Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 38 quarters.
  • Geode Capital Management's IVERIC bio, Inc. Common Stock position peaked at $63M in Q1 2023.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.